Johnson & Johnson Raises FY2026 Adj EPS Guidance from $11.43-$11.63 to $11.45-$11.65 vs $11.54 Est; Raises FY2026 Sales Guidance from $100.000B-$101.000B to $100.300B-$101.300B vs $100.575B Est

Johnson & Johnson (NYSE:JNJ) raises FY2026 Adj EPS guidance from $11.43-$11.63 to $11.45-$11.65 vs $11.54 analyst estimate. Raises FY2026 sales outlook from $100.000 billion-$101.000 billion to $100.300 billion-$101.300 billion vs $100.575 billion estimate.